|
HK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
8.75260000032796E-07 |
| Normal-vs-Stage3 |
2.09949999999681E-05 |
| Normal-vs-Stage4 |
2.303100E-03 |
| Stage1-vs-Stage2 |
2.638800E-01 |
| Stage1-vs-Stage3 |
5.072800E-01 |
| Stage1-vs-Stage4 |
3.046200E-01 |
| Stage2-vs-Stage3 |
2.336000E-01 |
| Stage2-vs-Stage4 |
1.841030E-01 |
| Stage3-vs-Stage4 |
6.638200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.58899584998562E-12 |
| Normal-vs-Asian |
1.496890E-03 |
| Caucasian-vs-AfricanAmerican |
1.099240E-01 |
| Caucasian-vs-Asian |
8.961500E-02 |
| AfricanAmerican-vs-Asian |
6.341000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
5.1236792586451E-13 |
| Male-vs-Female |
1.469450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.25260000038985E-07 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
4.48785453244227E-12 |
| Normal-vs-Extreme_Obese |
5.281100E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.758600E-01 |
| Normal_Weight-vs-Obese |
1.632440E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.630200E-01 |
| Extreme_Weight-vs-Obese |
8.398200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.975010E-01 |
| Obese-vs-Extreme_Obese |
8.880900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.220100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
4.42880000000034E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.603200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.579400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.025010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.987580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.5083999999983E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.460870E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.55573340268711E-13 |
| Normal-VS-KIRP CIMP |
9.095400E-03 |
| Normal-VS-Unclassified PRCC |
1.34969999621148E-08 |
| Type1 PRCC-VS-Type2 PRCC |
4.044400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.790160E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.160600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.349780E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.320200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.201200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.14469569776088E-11 |
| Normal-vs-N1 |
6.41080000000072E-05 |
| Normal-vs-N2 |
1.917860E-02 |
| N0-vs-N1 |
1.981010E-01 |
| N0-vs-N2 |
1.220940E-03 |
| N1-vs-N2 |
1.438010E-01 |
|
|
